Answers are grounded in this paper and cite their sources.
No direct evidence comparing melatonin receptor agonists with SSRIs for specific clinical conditions was identified. However, indirect evidence suggests potential advantages of melatonin receptor agonists in treating depression-associated insomnia, anxiety, and circadian rhythm disturbances.
No takes yet. Share an insight, caveat, or question.
Tripdatabase (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: